Status:

ACTIVE_NOT_RECRUITING

Phase I Trial of QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs in Acute-on-Chronic Liver Failure

Lead Sponsor:

Third Affiliated Hospital, Sun Yat-Sen University

Collaborating Sponsors:

Guangdong Qianhui Biotechnology Co., Ltd

Conditions:

Acute-On-Chronic Liver Failure

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

Brief Summary

The goal of this Phase I clinical trial is to evaluate the safety and efficacy of combining the QH-1A bioartificial liver device with mesenchymal stem cells(MSCs) for blood purification in treating pa...

Eligibility Criteria

Inclusion

  • Age between 18 and 65 years, irrespective of gender.
  • Patients with acute-on-chronic liver failure, diagnosed according to the - - Guideline for diagnosis and treatment of liver failure (2024 version) in China.
  • Subjects must provide informed consent prior to the study and voluntarily sign the written informed consent form.
  • Subjects must be able to communicate effectively with the investigators and comply with the study protocol.

Exclusion

  • Active bleeding or disseminated intravascular coagulation (DIC) that is not effectively controlled.
  • Allergies to the blood products or medications used during treatment.
  • Circulatory failure.
  • Occurrence of myocardial infarction, cerebral infarction, or cerebral hemorrhage within the past 6 months.
  • A history of malignant tumors within the past 5 years (except for cured basal cell carcinoma of the skin or carcinoma in situ of the cervix).
  • Any other conditions that, in the opinion of the investigator, render the subject unsuitable for participation in the study.

Key Trial Info

Start Date :

May 7 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT06996392

Start Date

May 7 2025

End Date

December 31 2026

Last Update

May 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Third Affiliated Hospital, Sun Yat-sen University

Guangzhou, Guangdong, China, 510630

Phase I Trial of QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs in Acute-on-Chronic Liver Failure | DecenTrialz